Skip to content
OpenCapital
Get started

Boundless Bio, Inc. BOLD Q1 2026 earnings

Reported May 8, 2026 · Before market open

EPS-$0.60Miss by $0.09
EPS estimate-$0.51

Next report

Aug 4, 2026 (In 6 days)
EPS estimate-$0.58

Versus estimates

Diluted EPS

Q1 2026-$0.60Miss by $0.09
Q4 2025-$0.58Miss by $0.14Q3 2025-$0.62Miss by $0.09Q2 2025-$0.70Beat by $0.05Q1 2025-$0.71Miss by $0.03Q4 2024-$0.74In line

Ask the moment Boundless Bio, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Boundless Bio, Inc. report Q1 2026 earnings?
Boundless Bio, Inc. (BOLD) reported Q1 2026 earnings on May 8, 2026 before market open.
What were Boundless Bio, Inc.'s Q1 2026 revenue and EPS?
Boundless Bio, Inc. reported eps of $-0.60 for Q1 2026.
Did Boundless Bio, Inc. beat estimates in Q1 2026?
EPS missed the consensus estimate of $-0.51 by $0.09.
How did Boundless Bio, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 15.5% from $-0.71.
Where can I find Boundless Bio, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-213269) and the 10-Q periodic report (0001193125-26-213321) directly on SEC EDGAR. The filing index links above go to sec.gov.